Selected article for: "admission respiratory failure and logistic regression"
Author: Testa, Renato Scarsi; Praça, Ana Paula Agnolon; Nassar Junior, Antonio Paulo; Santana, Pauliane Vieira; Okamoto, Valdelis Novis; Costa, Ramon Teixeira; Caruso, Pedro
Title: Mortality and Life-Sustaining Therapy Decisions in Patients With Cancer and Acute Respiratory Failure Due to COVID-19 or Other Causes: An Observational Study
  • Cord-id: rks7d5yo
  • Document date: 2021_5_3
    • ID: rks7d5yo
    Snippet: It is unknown if patients with cancer and acute respiratory failure due to COVID-19 have different clinical or cancer-related characteristics, decisions to forgo life-sustaining therapies (LST), and mortality compared to patients with cancer and acute respiratory failure due to other causes. In a cohort study, we tested the hypothesis that COVID-19 was associated with increased in-hospital mortality and decreased decisions to forgo LST in patients with cancer and acute respiratory failure. We em
    Document: It is unknown if patients with cancer and acute respiratory failure due to COVID-19 have different clinical or cancer-related characteristics, decisions to forgo life-sustaining therapies (LST), and mortality compared to patients with cancer and acute respiratory failure due to other causes. In a cohort study, we tested the hypothesis that COVID-19 was associated with increased in-hospital mortality and decreased decisions to forgo LST in patients with cancer and acute respiratory failure. We employed two multivariate logistic regression models. Propensity score matching was employed as sensitivity analysis. We compared 382 patients without COVID-19 with 65 with COVID-19. Patients with COVID-19 had better performance status, less metastatic tumors, and progressive cancer. In-hospital mortality of patients with COVID-19 was lower compared with patients without COVID-19 (46.2 vs. 74.6%; p < 0.01). However, the cause of acute respiratory failure (COVID-19 or other causes) was not associated with increased in-hospital mortality [adjusted odds ratio (OR) 1.27 (0.55–2.93; 95% confidence interval, CI)] in the adjusted model. The percentage of patients with a decision to forgo LST was lower in patients with COVID-19 (15.4 vs. 36.1%; p = 0.01). However, COVID-19 was not associated with decisions to forgo LST [adjusted OR 1.21 (0.44–3.28; 95% CI)] in the adjusted model. The sensitivity analysis confirmed the primary analysis. In conclusion, COVID-19 was not associated with increased in-hospital mortality or decreased decisions to forgo LST in patients with cancer and acute respiratory failure. These patients had better performance status, less progressive cancer, less metastatic tumors, and less organ dysfunctions upon intensive care unit (ICU) admission than patients with acute respiratory failure due to other causes.

    Search related documents:
    Co phrase search for related documents
    • absolute neutrophil count and admission icu intensive care unit: 1, 2, 3
    • acute cancer and admission icu intensive care unit: 1
    • acute cancer respiratory failure and admission icu intensive care unit: 1
    • acute cause respiratory failure and adjusted model: 1
    • acute cause respiratory failure and admission icu intensive care unit: 1, 2, 3
    • acute respiratory failure and adjusted model: 1, 2, 3, 4
    • acute respiratory failure and admission icu intensive care unit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory failure cancer and admission icu intensive care unit: 1
    • acyclic graph and admission icu intensive care unit: 1
    • adjusted model and admission icu intensive care unit: 1, 2, 3, 4, 5, 6